← Back to Search

Behavioural Intervention

Remote Monitoring for Bladder Cancer

N/A
Waitlist Available
Led By Kathryn Marchetti, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Undergoing cystectomy at single center
Be older than 18 years old
Must not have
Unwilling or unable to participate
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks following hospital discharge
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study the use of wearable activity monitors and smartphones to monitor patients who have had bladder cancer surgery. The goal is to improve post-operative care by detecting and addressing potential issues early. Patients

Who is the study for?
This trial is for English-speaking individuals who are undergoing cystectomy at a single center and own a smartphone. It's not open to those unwilling or unable to participate, non-English speakers, or those without a smartphone.
What is being tested?
The study tests if remote monitoring with FitBits and smartphones can improve care after bladder cancer surgery. Participants will be randomly assigned to either get continuous biomarker monitoring and daily health reports, with provider alerts for any issues, or standard post-operative care.
What are the potential side effects?
Since the intervention involves non-invasive technology like FitBits and smartphones for monitoring purposes rather than medication, traditional side effects are not expected. However, there may be privacy concerns related to data collection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for bladder removal surgery at one hospital.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am willing and able to participate in the trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks following hospital discharge
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks following hospital discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
patient engagement
provider response

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: remote monitoring without provider feedbackExperimental Treatment1 Intervention
remote monitoring with FitBit device and daily patient-reported outcome assessment, without real-time provider feedback
Group II: remote monitoring with provider feedbackExperimental Treatment2 Interventions
remote monitoring with FitBit device and daily patient-reported outcome assessment, as well as real-time provider feedback in response to remote data

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,789 Previous Clinical Trials
16,359,573 Total Patients Enrolled
Kathryn Marchetti, MDPrincipal InvestigatorUniversity of Pittsburgh Medical Center
~30 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top